Lila Biologics, Inc.
Lila Bio is a therapeutic biotechnology company that applies machine learning and high-throughput experimental platforms to design and develop protein therapeutics. The company's stated focus areas include targeted radioligand therapies for solid tumors and long-acting injectable protein therapeutics for non-oncology indications. Their approach combines computational protein design, experimental optimization for affinity and selectivity, chemistry for conjugation and synthesis, and formulation/developability work aimed at subcutaneous delivery and tailored pharmacokinetics.
Industries
N/A
Services
Discovery and preclinical development of AI-designed protein therapeutics
End-to-end discovery workflows that combine computational design and experimental optimization to produce development candidates for oncology and non-oncology indications.
Discovery and preclinical development of AI-designed protein therapeutics
End-to-end discovery workflows that combine computational design and experimental optimization to produce development candidates for oncology and non-oncology indications.
Expertise Areas
- AI-enabled protein design
- Protein engineering and de novo binder design
- Radioligand/targeted radiotherapy development
- Long-acting injectable therapeutics
Key Technologies
- AI-driven protein design
- De novo protein design
- Computational protein modeling (diffusion-based methods)
- Unnatural/noncanonical amino acid incorporation